Notice to update Application Types Allowed for PAR-18-464: Clinical and Translational Science Award (U54 Clinical Trial Optional)

Notice Number: NOT-TR-18-028

Key Dates
Release Date: June 11, 2018

Related Announcements
PAR-18-464

Issued by
National Center for Advancing Translational Sciences (NCATS)

Purpose

The purpose of this Notice is to update Application Types Allowed for PAR-18-464: Clinical and Translational Science Award (U54 Clinical Trial Optional).

Section II. Award Information

Application Types Allowed

Currently Reads:

New
Renewals for RFA-TR-14-009
Resubmissions for RFA-TR-14-009, PAR-15-304 and this FOA.
Applications from institutions that currently have a CTSA award will be considered as new applications unless:
They are resubmission or renewals of applications submitted to RFA-TR-14-009, or;
They are resubmissions from PAR-15-304 and this FOA.
The OER Glossary and the SF424 (R&R) Application Guide provide details on these application types.

Revised to Read:

New
Renewals for RFA-TR-14-009 and PAR-15-304
Resubmissions for PAR-15-304 and this FOA.
Applications from institutions that currently have a CTSA award will be considered as new applications unless:
They are renewals of applications submitted to RFA-TR-14-009 or PAR-15-304, or;
They are resubmissions from PAR-15-304 and this FOA.
The OER Glossary and the SF424 (R&R) Application Guide provide details on these application types.

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Mary E. Purucker, M.D.
National Center for Advancing Translational Services (NCATS)
Telephone: 301-435-0741
Email: [email protected]